Spatiotemporal analysis of impaired microglia process movement at sites of secondary neurodegeneration post-stroke

J Cereb Blood Flow Metab. 2019 Dec;39(12):2456-2470. doi: 10.1177/0271678X18797346. Epub 2018 Sep 11.

Abstract

It has recently been identified that after motor cortex stroke, the ability of microglia processes to respond to local damage cues is lost from the thalamus, a major site of secondary neurodegeneration (SND). In this study, we combine a photothrombotic stroke model in mice, acute slice and fluorescent imaging to analyse the loss of microglia process responsiveness. The peri-infarct territories and thalamic areas of SND were investigated at time-points 3, 7, 14, 28 and 56 days after stroke. We confirmed the highly specific nature of non-responsive microglia processes to sites of SND. Non-responsiveness was at no time observed at the peri-infarct but started in the thalamus seven days post-stroke and persisted for 56 days. Loss of directed process extension is not a reflection of general functional paralysis as phagocytic function continued to increase over time. Additionally, we identified that somal P2Y12 was present on non-responsive microglia in the first two weeks after stroke but not at later time points. Finally, both classical microglia activation and loss of process extension are highly correlated with neuronal damage. Our findings highlight the importance of microglia, specifically microglia dynamic functions, to the progression of SND post-stroke, and their potential relevance as modulators or therapeutic targets during stroke recovery.

Keywords: Microglia motility; laser injury; live cell multi-photon imaging; stroke recovery; thalamus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Mice
  • Mice, Transgenic
  • Microglia / metabolism*
  • Microglia / pathology
  • Neurodegenerative Diseases / etiology
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology
  • Receptors, Purinergic P2Y12 / genetics
  • Receptors, Purinergic P2Y12 / metabolism*
  • Stroke / complications
  • Stroke / genetics
  • Stroke / metabolism*
  • Stroke / pathology
  • Thalamus / metabolism*
  • Thalamus / pathology
  • Time Factors

Substances

  • P2ry12 protein, mouse
  • Receptors, Purinergic P2Y12